Myopia: Keeping it under control

Coopervision: MiSight 1 day

CooperVision says MiSight 1 day is the world’s first CE-marked, soft daily disposable contact lens proven to significantly slow the progression of myopia in children and therefore lower the risk of myopia-related ocular conditions later in life.

The company states that the advanced lens design utilises innovative ActivControl technology to control both axial elongation and myopia progression, while fully correcting refractive error. Two treatment zones create myopic defocus with an image focused in front of the retina, rather than behind it, to slow axial elongation, while two correction zones correct myopia in all gaze positions.

CooperVision says its research into MiSight 1 day’s effectiveness has been far-reaching and includes a gold standard prospective, multi-centre, double-masked, randomised multi-year study that enrolled 144 myopic children aged eight to 12 years from Singapore, Canada, the UK and Portugal. Three-year peer-reviewed results published in Optometry and Vision Science indicated use of MiSight 1 day was shown to slow myopia progression: 59% as measured by mean cycloplegic spherical equivalent and 52% as measured by mean axial elongation of the eye.